Palvella Therapeutics Officer Jeffrey Martini Files Form 144 to Sell 50,000 Shares via Rule 144
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Jeffrey Martini, an officer at Palvella Therapeutics, Inc., has filed a Form 144 to sell 50,000 shares of common stock. The transaction, valued at $8,704,000.00, will be conducted under Rule 144 of the Securities Act of 1933 and a Rule 10b5-1 trading plan adopted in July 2026. These shares are derived from the exercise of stock options.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.